Adage Capital Management, L.P. has acquired a 5.81% stake in First Tracks Biotherapeutics, signaling increased interest in the pharmaceutical sector.
| Name | First Tracks Biotherapeutics, Inc. |
|---|---|
| CIK | 0002091349 |
| Tickers | TRAX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 395003207 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 212-373-3000 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Adage Capital Management, L.P. has acquired a 5.81% stake in First Tracks Biotherapeutics, signaling increased interest in the pharmaceutical sector.
FMR LLC discloses a 15% ownership stake in First Tracks Biotherapeutics, reflecting increased interest in the pharmaceutical sector.
First Tracks Biotherapeutics, Inc. files a prospectus supplement to sell 6.1 million shares of common stock, indicating a strategic liquidity move.
First Tracks Biotherapeutics' CMO Paul F. Lizzul acquires 42,500 shares, reflecting the company's performance-based incentive strategy in the pharmaceutical sector.
First Tracks Biotherapeutics CEO Daniel Faga acquires 136,000 shares, reflecting alignment of executive compensation with shareholder interests.
First Tracks Biotherapeutics CFO Ajim Tamboli reports a stock transaction, emphasizing performance-based incentives in executive compensation.
First Tracks Biotherapeutics, Inc. announces its Q3 2026 financial results, highlighting key developments in the pharmaceutical preparations sector.
First Tracks Biotherapeutics announces its financial results for Q3 2026, showcasing its performance in the pharmaceutical preparations sector.
First Tracks Biotherapeutics has secured SEC approval for its S-1 registration statement, paving the way for its public offering.
BlackRock, Inc. has reported a 7.2% ownership stake in First Tracks Biotherapeutics, highlighting significant interest in the pharmaceutical sector.
First Tracks Biotherapeutics, Inc. has filed for an initial public offering, marking a significant step in its growth strategy within the pharmaceutical industry.
First Tracks Biotherapeutics shares positive topline data from its Phase 1b cohort of ANB033 in Celiac Disease, signaling growth potential in the pharmaceutical sector.
100 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-007578 | 005-95624 | 261543967 | 34 | 15853 | |||
| 2026-11-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002942 | 005-95624 | 261529782 | 34 | 11893 | |||
| 2026-11-04 | 424B3 | 424B3 | 0001193125-26-447243 | 333-299632 | 261522255 | 33 | 2405764 | |||
| 2026-11-04 | 424B3 | 424B3 | 0001193125-26-447205 | 333-295719 | 261522062 | 33 | 2405758 | |||
| 2026-11-03 | 4 | xslF345X06/form4-11032026_111158.xml | 0001855684-26-000009 | 6897 | ||||||
| 2026-11-03 | 4 | xslF345X06/form4-11032026_111129.xml | 0001673528-26-000018 | 6896 | ||||||
| 2026-11-03 | 4 | xslF345X06/form4-11032026_111155.xml | 0002128786-26-000007 | 6896 | ||||||
| 2026-11-03 | 4 | xslF345X06/form4-11032026_111123.xml | 0001711462-26-000015 | 6911 | ||||||
| 2026-11-03 | 10-Q | 10-Q | 0001193125-26-445430 | 001-43177 | 261517884 | 34 | 10678306 | 1 | 1 | |
| 2026-11-03 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-445405 | 001-43177 | 261517741 | 34 | 423172 | 1 | 1 |
| 2026-10-29 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003380 | 333-299632 | 261504256 | 33 | 1884 | ||
| 2026-10-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-003898 | 005-95624 | 261491743 | 34 | 11210 | |||
| 2026-10-26 | S-1 | S-1 | 0001193125-26-431033 | 333-299632 | 261483550 | 33 | 11152452 | 1 | 1 | |
| 2026-10-20 | 8-K | 8-K | 1.01,9.01 | 0001193125-26-426666 | 001-43177 | 261472721 | 34 | 446072 | 1 | 1 |
| 2026-10-15 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-26-422929 | 001-43177 | 261463373 | 34 | 990407 | 1 | 1 |
| 2026-10-13 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-419761 | 001-43177 | 261454833 | 34 | 19115359 | 1 | 1 |
| 2026-09-17 | 4 | xslF345X06/form4-09172026_040901.xml | 0001477384-26-000012 | 7474 | ||||||
| 2026-09-04 | 4 | xslF345X06/form4-09042026_080925.xml | 0001715429-26-000007 | 11457 | ||||||
| 2026-09-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008997 | 001-43177 | 261354902 | 33 | 4827 | |||
| 2026-08-18 | 4 | xslF345X06/form4-08182026_040807.xml | 0002128786-26-000006 | 6152 | ||||||
| 2026-08-18 | 4 | xslF345X06/form4-08182026_040804.xml | 0001711462-26-000014 | 6167 | ||||||
| 2026-08-18 | 4 | xslF345X06/form4-08182026_040802.xml | 0001673528-26-000017 | 6151 | ||||||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-352354 | 005-95624 | 261282237 | 34 | 96684 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-005204 | 005-95624 | 261276435 | 34 | 15031 | |||
| 2026-08-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001011438-26-000512 | 005-95624 | 261273367 | 34 | 15663 | |||
| 2026-08-13 | 424B3 | 424B3 | 0001193125-26-349146 | 333-295719 | 261273129 | 33 | 2248788 | |||
| 2026-08-12 | 10-Q | 10-Q | 0001193125-26-346931 | 001-43177 | 261267875 | 34 | 11305977 | 1 | 1 | |
| 2026-08-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-346908 | 001-43177 | 261267788 | 34 | 401533 | 1 | 1 |
| 2026-08-07 | 3/A | xslF345X06/form3a-08072026_090830.xml | 0001711462-26-000013 | 4944 | ||||||
| 2026-08-07 | 3/A | xslF345X06/form3a-08072026_090843.xml | 0002128786-26-000005 | 10003 | ||||||
| 2026-08-07 | 3/A | xslF345X06/form3a-08072026_090846.xml | 0001673528-26-000015 | 4926 | ||||||
| 2026-08-06 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002002 | 005-95624 | 261246988 | 34 | 11602 | |||
| 2026-08-05 | 4 | xslF345X06/form4-08052026_100823.xml | 0002128786-26-000004 | 6149 | ||||||
| 2026-08-05 | 4 | xslF345X06/form4-08052026_100845.xml | 0001711462-26-000011 | 6164 | ||||||
| 2026-08-05 | 4 | xslF345X06/form4-08052026_100851.xml | 0001673528-26-000014 | 6149 | ||||||
| 2026-07-28 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002568 | 005-95624 | 261212607 | 34 | 11090 | |||
| 2026-06-22 | 8-K | 8-K | 1.01 | 0001193125-26-277504 | 001-43177 | 261107019 | 34 | 154793 | 1 | 1 |
| 2026-06-17 | 4 | xslF345X06/form4-06172026_040621.xml | 0001707797-26-000010 | 9774 | ||||||
| 2026-06-17 | 4 | xslF345X06/form4-06172026_040617.xml | 0001478916-26-000012 | 7353 | ||||||
| 2026-06-17 | 4 | xslF345X06/form4-06172026_040615.xml | 0001477384-26-000011 | 7353 | ||||||
| 2026-06-17 | 4 | xslF345X06/form4-06172026_040619.xml | 0001715429-26-000006 | 7381 | ||||||
| 2026-06-17 | 4 | xslF345X06/form4-06172026_040614.xml | 0001631486-26-000008 | 7352 | ||||||
| 2026-06-17 | 4 | xslF345X06/form4-06172026_040612.xml | 0001184627-26-000007 | 7359 | ||||||
| 2026-06-12 | 4/A | xslF345X06/form4a-06122026_080633.xml | 0001184627-26-000006 | 8658 | ||||||
| 2026-06-12 | 4/A | xslF345X06/form4a-06122026_080656.xml | 0001707797-26-000009 | 8665 | ||||||
| 2026-06-12 | 4/A | xslF345X06/form4a-06122026_080618.xml | 0001631486-26-000007 | 8651 | ||||||
| 2026-06-12 | 4/A | xslF345X06/form4a-06122026_080638.xml | 0001477384-26-000009 | 8652 | ||||||
| 2026-06-12 | 4/A | xslF345X06/form4a-06122026_080641.xml | 0001478916-26-000010 | 8652 | ||||||
| 2026-06-12 | 4/A | xslF345X06/form4a-06122026_080644.xml | 0001715429-26-000005 | 8680 | ||||||
| 2026-05-15 | 424B3 | 424B3 | 0001193125-26-226656 | 333-295719 | 26987120 | 33 | 1742471 | |||
| 2026-05-14 | 424B3 | 424B3 | 0001193125-26-224317 | 333-295719 | 26980394 | 33 | 2171421 | |||
| 2026-05-14 | 10-Q | 10-Q | 0001193125-26-224190 | 001-43177 | 26979656 | 34 | 9091379 | 1 | 1 | |
| 2026-05-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-224124 | 001-43177 | 26979420 | 34 | 317786 | 1 | 1 |
| 2026-05-14 | 4 | xslF345X06/form4-05142026_040518.xml | 0001715429-26-000004 | 8620 | ||||||
| 2026-05-14 | 4 | xslF345X06/form4-05142026_040513.xml | 0001631486-26-000006 | 8590 | ||||||
| 2026-05-14 | 4 | xslF345X06/form4-05142026_040516.xml | 0001478916-26-000007 | 8592 | ||||||
| 2026-05-14 | 4 | xslF345X06/form4-05142026_040511.xml | 0001707797-26-000006 | 8604 | ||||||
| 2026-05-14 | 4 | xslF345X06/form4-05142026_040515.xml | 0001477384-26-000006 | 8591 | ||||||
| 2026-05-14 | 4 | xslF345X06/form4-05142026_040509.xml | 0001184627-26-000005 | 8597 | ||||||
| 2026-05-14 | 4 | xslF345X06/form4-05142026_040505.xml | 0002128786-26-000003 | 8641 | ||||||
| 2026-05-14 | 4 | xslF345X06/form4-05142026_040507.xml | 0001673528-26-000013 | 8647 | ||||||
| 2026-05-14 | 4 | xslF345X06/form4-05142026_040503.xml | 0001855684-26-000008 | 8639 | ||||||
| 2026-05-14 | 4 | xslF345X06/form4-05142026_040501.xml | 0001711462-26-000010 | 8656 | ||||||
| 2026-05-12 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001596 | 333-295719 | 26970721 | 33 | 1883 | ||
| 2026-05-08 | CORRESP | filename1.htm | 0000950142-26-001339 | 7660 | ||||||
| 2026-05-08 | S-1 | S-1 | 0001193125-26-214778 | 333-295719 | 26959089 | 33 | 3737157 | 1 | 1 | |
| 2026-05-06 | UPLOAD | filename1.pdf | 0000000000-26-004652 | 377-09320 | 152472 | |||||
| 2026-05-01 | DRS | filename1.htm | 0001193125-26-201224 | 377-09320 | 26931964 | 33 | 3679608 | |||
| 2026-04-23 | 4 | xslF345X06/form4-04232026_100450.xml | 0001855684-26-000007 | 12573 | ||||||
| 2026-04-23 | 3 | xslF345X06/form3-04232026_100415.xml | 0001855684-26-000006 | 3360 | ||||||
| 2026-04-22 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000935836-26-000209 | 005-95624 | 26884673 | 34 | 16055 | |||
| 2026-04-22 | 4 | xslF345X06/ownership.xml | 0000935836-26-000208 | 6705 | ||||||
| 2026-04-22 | 3 | xslF345X06/ownership.xml | 0000935836-26-000207 | 5721 | ||||||
| 2026-04-22 | 3 | xslF345X06/form3-04222026_080413.xml | 0002128786-26-000002 | 25550 | ||||||
| 2026-04-22 | 4 | xslF345X06/form4-04222026_040419.xml | 0001711462-26-000009 | 36380 | ||||||
| 2026-04-22 | 4 | xslF345X06/form4-04222026_040417.xml | 0001715429-26-000003 | 39637 | ||||||
| 2026-04-22 | 4 | xslF345X06/form4-04222026_040415.xml | 0001478916-26-000005 | 37453 | ||||||
| 2026-04-22 | 4 | xslF345X06/form4-04222026_040413.xml | 0001477384-26-000004 | 29135 | ||||||
| 2026-04-22 | 4 | xslF345X06/form4-04222026_040411.xml | 0001184627-26-000004 | 37460 | ||||||
| 2026-04-22 | 4 | xslF345X06/form4-04222026_040409.xml | 0001707797-26-000005 | 29140 | ||||||
| 2026-04-22 | 4 | xslF345X06/form4-04222026_040403.xml | 0001370053-26-000005 | 6333 | ||||||
| 2026-04-22 | 4 | xslF345X06/form4-04222026_040401.xml | 0001673528-26-000010 | 36706 | ||||||
| 2026-04-22 | 4 | xslF345X06/form4-04222026_040407.xml | 0001631486-26-000005 | 30988 | ||||||
| 2026-04-20 | 8-K | 8-K | 1.01,2.01,3.02,3.03,5.01,5.02,5.03,8.01,9.01 | 0001193125-26-164328 | 001-43177 | 26876104 | 34 | 1341831 | 1 | 1 |
| 2026-04-17 | S-8 | S-8 | 0001193125-26-161758 | 333-295167 | 26872498 | 33 | 499462 | 1 | 1 | |
| 2026-04-03 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-140835 | 001-43177 | 26836363 | 34 | 4956352 | 1 | 1 |
| 2026-04-01 | 3 | xslF345X06/form3-04012026_080454.xml | 0001715429-26-000002 | 3362 | ||||||
| 2026-04-01 | 3 | xslF345X06/form3-04012026_080408.xml | 0001707797-26-000004 | 3341 | ||||||
| 2026-04-01 | 3 | xslF345X06/form3-04012026_080407.xml | 0001478916-26-000003 | 3333 | ||||||
| 2026-04-01 | 3 | xslF345X06/form3-04012026_080419.xml | 0001184627-26-000003 | 3341 | ||||||
| 2026-04-01 | 3 | xslF345X06/form3-04012026_080439.xml | 0001631486-26-000004 | 3331 | ||||||
| 2026-04-01 | 3 | xslF345X06/form3-04012026_080449.xml | 0001477384-26-000003 | 3332 | ||||||
| 2026-04-01 | 3 | xslF345X06/form3-04012026_080414.xml | 0001711462-26-000008 | 3358 | ||||||
| 2026-04-01 | 3 | xslF345X06/form3-04012026_080431.xml | 0001673528-26-000009 | 3337 | ||||||
| 2026-04-01 | 3 | xslF345X06/form3-04012026_080435.xml | 0001370053-26-000004 | 4961 | ||||||
| 2026-04-01 | SEC STAFF ACTION | filename1.pdf | 9999999997-26-000597 | 4231 | ||||||
| 2026-04-01 | CERT | TRAX_Form10_Cert_0002091349.pdf | 0001354457-26-000320 | 001-43177 | 26827744 | 34 | 193583 | |||
| 2026-03-27 | 10-12B/A | 10-12B/A | 0001193125-26-129178 | 001-43177 | 26807911 | 34 | 5915525 | |||
| 2026-03-03 | 10-12B | 10-12B | 0001193125-26-088399 | 001-43177 | 26715162 | 34 | 5414111 | |||
| 2026-02-06 | DRS | filename1.htm | 0001193125-26-041117 | 377-09015 | 26607414 | 33 | 2283805 |
One latest value per concept from companyfacts (147 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 42.02M | 2026-10-29 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 22,022.29 | 2026-10-23 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 22,022.29 | 2026-10-23 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 253.13M | 2026-10-23 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-10-23 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-10-23 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 3.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | AccountsReceivableFromSecuritization | Accounts Receivable from Securitization | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 11.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 7.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 206.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 8.90M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 11.50M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001193125-26-224190 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 9.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | AreaOfLand | Area of Land | sqft | 45,000 | 2026-06-15 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | Assets | Assets | USD | 170.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 165.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 183,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 0 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 73.26M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 73.44M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 23,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001193125-26-224190 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 155.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 155.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -82.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 35.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 35.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 36,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -115.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | CurrentFederalStateAndLocalTaxExpenseBenefit | Current Federal, State and Local, Tax Expense (Benefit) | USD | -166.09M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | -166.09M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2024-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 32.83M | 2024-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 32.83M | 2024-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 2.39M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 134.32M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 37.29M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 131.92M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 48.14M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 229.20M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 49.50M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 9.72M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 25.84M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 13.33M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 131.92M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 2.39M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 2.30M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage | Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage | pure | 1 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount | USD | 23,500 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent | pure | 0.1 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 322,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -3.25 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -3.25 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 363,000 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 4.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 48.20M | 2026-06-30 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 37.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 32.78M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -34.88M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.49M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -14,000 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 6.80M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | -6.60M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 15.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -985,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 11.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 5.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 4.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 2.00M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 658,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 2.93M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 2.85M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 708,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 2.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 278,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 170.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 18.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 0 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | MembersCapital | Members' Capital | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | -36.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 34.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -81.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -115.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 5.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | ReportableSegment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 120.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -120.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 3.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 2.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 1.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 3.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 1.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.095 | 2026-06-15 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 2.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | 24,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | 146,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -9,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 10.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 42,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 10.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | PrepaidRent | Prepaid Rent | USD | 0 | 2026-06-15 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | ProceedsFromContributionsFromParent | Proceeds from Contributions from Parent | USD | 100.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 75.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 109.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 469,000 | 2026-01-01 | 2026-06-30 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 35.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 7.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 8.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 979,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | ReceivablesFromCustomers | Receivables from Customers | USD | 2.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 83.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -55.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 4.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | SecurityDeposit | Security Deposit | USD | 300,000 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 28.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 1.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 6.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 151.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 4.68M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 80.00M | 2026-04-20 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -138,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 6.07M | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | |||
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 2,000 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense | Unrecognized Tax Benefits, Income Tax Penalties Expense | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 1.86M | 2025-01-01 | 2025-12-31 | S-1 | 2026-10-26 | 0001193125-26-431033 | ||
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 35.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 35.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001193125-26-445430 |